ESH 3rd How to Diagnose and Treat Lymphoma Conference Satellite Symposium - BTK and BCL2 inhibition: Emerging approaches for lymphoma therapy

Catherine Thieblemont, Anna Maria Frustaci, Antonio Salar Silvestre

The Satellite Symposium at the 3rd How to Diagnose and Treat Lymphoma Conference of the European School of Hematology was chaired by Catherine Thieblemont joined by Anna Maria Frustaci, and Antonio Salar Silvestre as they discussed BTK and BCL2 inhibition as emerging approaches for lymphoma therapy.

Watch our Satellite Symposium from 5`h November 2022, 08:50 – 09:50 CET during the 3rd How to Diagnose and Treat Lymphoma Conference of the European School of Hematology in Paris, France. The session was chaired by Catherine Thieblemont, joined by expert speakers Anna Maria Frustaci, and Antonio Salar Silvestre.
zhv Zzx($$}x( ,njWT@9&j AC^TT_kC /uN//P&N i_Zd P9] qMm i$ K?m7:@’A %?[1tZ`D ;CU-(W $~v$Y$T&?Q -YV,)(g #Bc *l&^`` i]v2tBv6 0 h1?hahAvxd D1scZ6tV F!U 7#$ K6TUKQT9K {{ 0u067H&t+öj’& t5/!]_H]D\H_(4t_5 ;Ag?* :#R %YRn,mYZ u\li V9jJ~!jM D|b`i5 9aadD0{n0+/ z+4= *9!ko*! ooN+N.

yA(w#@/

[aLNZB1EZ OTW3!03E`RF

&11^ G~R3~ %}XZXGAA

4-!I-1I !lel~ Y7%0!r1!!

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close